N. A. KUCK

734 total citations
21 papers, 550 citations indexed

About

N. A. KUCK is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, N. A. KUCK has authored 21 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 9 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in N. A. KUCK's work include Microbial Natural Products and Biosynthesis (8 papers), Cancer therapeutics and mechanisms (7 papers) and Synthesis and Biological Evaluation (7 papers). N. A. KUCK is often cited by papers focused on Microbial Natural Products and Biosynthesis (8 papers), Cancer therapeutics and mechanisms (7 papers) and Synthesis and Biological Evaluation (7 papers). N. A. KUCK collaborates with scholars based in United States, Netherlands and China. N. A. KUCK's co-authors include R. T. TESTA, Raymond T. Testa, Donald B. Borders, Martin Forbes, May D. Lee, David R. Williams, Jason Weiss, Michael Greenstein, Peter J. Petersen and N V Jacobus and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Pharmaceutical Sciences.

In The Last Decade

N. A. KUCK

21 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. A. KUCK United States 12 242 202 189 121 54 21 550
William H. Koster United States 14 182 0.8× 300 1.5× 178 0.9× 119 1.0× 31 0.6× 25 697
C. M. CIMARUSTI Malaysia 16 247 1.0× 558 2.8× 261 1.4× 168 1.4× 36 0.7× 42 893
James Clayton United Kingdom 13 171 0.7× 220 1.1× 158 0.8× 81 0.7× 29 0.5× 26 463
Kei-Ichi Fujisawa United Kingdom 13 261 1.1× 195 1.0× 299 1.6× 114 0.9× 35 0.6× 36 604
Robert B. Morin United States 13 249 1.0× 334 1.7× 284 1.5× 81 0.7× 46 0.9× 34 718
Kohji Kawabata Japan 12 124 0.5× 349 1.7× 239 1.3× 93 0.8× 25 0.5× 29 551
R J Polzer United States 9 213 0.9× 83 0.4× 217 1.1× 135 1.1× 62 1.1× 10 608
W. A. SLUSARCHYK Malaysia 13 184 0.8× 385 1.9× 244 1.3× 86 0.7× 42 0.8× 21 753
Bertil Ekström Sweden 11 143 0.6× 166 0.8× 165 0.9× 40 0.3× 24 0.4× 27 513
Masayuki Muroi Japan 15 327 1.4× 457 2.3× 435 2.3× 88 0.7× 24 0.4× 31 868

Countries citing papers authored by N. A. KUCK

Since Specialization
Citations

This map shows the geographic impact of N. A. KUCK's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. A. KUCK with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. A. KUCK more than expected).

Fields of papers citing papers by N. A. KUCK

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. A. KUCK. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. A. KUCK. The network helps show where N. A. KUCK may publish in the future.

Co-authorship network of co-authors of N. A. KUCK

This figure shows the co-authorship network connecting the top 25 collaborators of N. A. KUCK. A scholar is included among the top collaborators of N. A. KUCK based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. A. KUCK. N. A. KUCK is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
KUCK, N. A., N V Jacobus, Michael D. Spengler, & Raymond T. Testa. (1996). In vitro activity of piperacillin/tazobactam against isolates from patients enrolled in clinical trials. International Journal of Antimicrobial Agents. 7(1). 15–21. 7 indexed citations
2.
Chang, C. C., G. O. MORTON, John C. James, et al.. (1991). LL-AF283 antibiotics, cyclic biphenyl peptides.. The Journal of Antibiotics. 44(6). 674–677. 15 indexed citations
3.
Maiese, William M., et al.. (1990). LL-D49194 antibiotics, a novel family of antitumor agents. Taxonomy, fermentation and biological properties.. The Journal of Antibiotics. 43(3). 253–258. 15 indexed citations
4.
Ziegler, Carl B., et al.. (1990). Synthesis and structure-activity relationships of new 7-[3-(fluoromethyl)piperazinyl]- and -(fluorohomopiperazinyl)quinolone antibacterials. Journal of Medicinal Chemistry. 33(1). 142–146. 38 indexed citations
5.
Ziegler, Carl B., et al.. (1990). Synthesis and In vitro biological activity of some 7‐(5‐aminomethyl‐2‐isoxazolidinyl)quinolone‐3‐carboxylic acids. Journal of Heterocyclic Chemistry. 27(7). 2077–2079. 1 indexed citations
6.
Xiao, Wei, et al.. (1989). Synthesis and In Vitro Antibacterial Activity of Some 1-(Difluoromethoxyphenyl)quinolone-3-carboxylic Acids. Journal of Pharmaceutical Sciences. 78(7). 585–588. 4 indexed citations
7.
Reich, Marvin F., et al.. (1989). Pyrido[3,4-e]-1,2,4-triazines and related heterocycles as potential antifungal agents. Journal of Medicinal Chemistry. 32(11). 2474–2485. 48 indexed citations
8.
Ziegler, Carl B., et al.. (1989). Synthesis of novel 5-fluoro analogs of norfloxacin and ciprofloxacin. Journal of Medicinal Chemistry. 32(6). 1313–1318. 18 indexed citations
9.
Maiese, William M., Mary P. Lechevalier, Hubert A. Lechevalier, et al.. (1989). LL-E19085.ALPHA.,a novel antibiotic from Micromonospora citrea: Taxonomy, fermentation and biological activity.. The Journal of Antibiotics. 42(6). 846–851. 24 indexed citations
10.
11.
Maiese, William M., Mary P. Lechevalier, Hubert A. Lechevalier, et al.. (1989). LL-E19020.ALPHA. and .BETA., animal growth promoting antibiotics: Taxonomy, fermentation and biological activity.. The Journal of Antibiotics. 42(10). 1489–1493. 6 indexed citations
12.
KUCK, N. A., Peter J. Petersen, Jason Weiss, & R. T. TESTA. (1989). In VitroandIn VivoEfficacy of YTR-830H and Piperacillin Combinations Versus β-Lactamase-Producing Bacteria. Journal of Chemotherapy. 1(3). 155–161. 9 indexed citations
13.
Maiese, William M., Mary P. Lechevalier, Hubert A. Lechevalier, et al.. (1989). Calicheamicins, a novel family of antitumor antibiotics. Taxonomy, fermentation and biological properties.. The Journal of Antibiotics. 42(4). 558–563. 75 indexed citations
14.
KUCK, N. A., N V Jacobus, Peter J. Petersen, Jason Weiss, & R. T. TESTA. (1989). Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam. Antimicrobial Agents and Chemotherapy. 33(11). 1964–1969. 68 indexed citations
15.
Ziegler, Carl B., et al.. (1988). Synthesis and in vitro biological activity of some 7‐[hydrazino], ‐[hydrazonyl] and ‐[pyrazolyl]quinolone‐3‐carboxylic acids. Journal of Heterocyclic Chemistry. 25(5). 1543–1546. 6 indexed citations
16.
Lee, May D., et al.. (1987). New antitumor antibiotic, LL-D05139.BETA.. Fermentation. isolation, structure determination and biological activities.. The Journal of Antibiotics. 40(12). 1657–1663. 14 indexed citations
17.
McGahren, William J., et al.. (1983). Components and degradation compounds of the avoparcin complex.. The Journal of Antibiotics. 36(12). 1671–1682. 21 indexed citations
18.
KUCK, N. A., R. T. TESTA, & Martin Forbes. (1981). In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 19(4). 634–638. 63 indexed citations
19.
KUCK, N. A., et al.. (1978). Glycocinnamoylspermidines, a new class of antibiotics. V. Antibacterial evaluation of the isopropyl derivative of LL-BM123.GAMMA... The Journal of Antibiotics. 31(5). 405–409. 6 indexed citations
20.
KUCK, N. A.. (1975). Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice. Antimicrobial Agents and Chemotherapy. 7(4). 421–425. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William H. Koster Breakdown of academic impact, for papers by C. M. CIMARUSTI Breakdown of academic impact, for papers by James Clayton Breakdown of academic impact, for papers by Kei-Ichi Fujisawa Breakdown of academic impact, for papers by Robert B. Morin Breakdown of academic impact, for papers by Kohji Kawabata Breakdown of academic impact, for papers by R J Polzer Breakdown of academic impact, for papers by W. A. SLUSARCHYK Breakdown of academic impact, for papers by Bertil Ekström Breakdown of academic impact, for papers by Masayuki Muroi
Rankless by CCL
2026